# A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

> **NCT02511990** · PHASE1 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 33 (actual)

## Conditions studied

- Healthy
- HIV

## Interventions

- **BIOLOGICAL:** 3 mg/kg, single dose IV administration of 10-1074
- **BIOLOGICAL:** 10 mg/kg, single dose IV administration of 10-1074
- **BIOLOGICAL:** 30 mg/kg, single dose IV administration of 10-1074

## Key facts

- **NCT ID:** NCT02511990
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02511990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02511990, "A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02511990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*